Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome.
Anderson, G, Berk, M, Maes, M · Acta psychiatrica Scandinavica · 2014 · DOI
Quick Summary
This review examined research showing that the physical symptoms experienced in ME/CFS, depression, and somatization (medically unexplained symptoms) have real biological causes, not just psychological ones. The authors found that inflammation, immune system activation, and changes in how the body breaks down certain nutrients are linked to symptoms like fatigue, pain, and autonomic problems. Understanding these biological pathways may help explain why these conditions overlap and why symptoms feel so physically real.
Why It Matters
This work validates that ME/CFS symptoms have measurable biological underpinnings rather than being primarily psychological, which is crucial for patient recognition and clinical legitimacy. Identifying shared immune-inflammatory pathways across depression, somatization, and ME/CFS may inform better diagnostic approaches and targeted treatments for conditions that are often dismissed or misdiagnosed.
Observed Findings
Inflammation and cell-mediated immune activation are associated with fatigue, malaise, and autonomic symptoms in depression, ME/CFS, and somatization.
Tryptophan catabolite (TRYCAT) pathway dysfunction correlates with physio-somatic symptoms including hyperalgesia, intestinal hypermotility, and peripheral neuropathy.
Oxidative and nitrosative stress induces neoepitopes and autoimmune responses that contribute to immuno-inflammatory processes in these conditions.
Shared biomarkers of immune activation exist across depression, somatization, and ME/CFS, suggesting biological overlap among these diagnostic categories.
Inferred Conclusions
Physio-somatic symptoms in ME/CFS, depression, and somatization are underpinned by measurable biological processes rather than being purely psychological in origin.
Immune-inflammatory pathways and tryptophan metabolism dysfunction are mechanistically linked to the physical symptoms observed across these overlapping conditions.
Reframing 'psychosomatic' symptoms as 'physio-somatic' better reflects the biological reality of these conditions and may improve clinical conceptualization and patient care.
Remaining Questions
Which specific biomarker combinations best predict symptom severity and prognosis in ME/CFS, and do they differ from patterns in depression or somatization?
Are the identified immune-inflammatory pathways primary drivers of disease or secondary consequences of another underlying process?
What This Study Does Not Prove
This review does not establish causation definitively—it identifies associations and correlations in existing literature. It does not prove these biological pathways are the sole cause of symptoms in all patients, nor does it demonstrate that all patients with these diagnoses share identical biomarker profiles. The narrative methodology also cannot quantify the strength or consistency of findings across studies.
Can targeting specific pathways (e.g., TRYCAT metabolism, oxidative stress) through intervention lead to symptom improvement, and which patients would benefit most?